Frazer A - Search Results

1

Vagal Nerve Stimulation for Treatment-Resistant Depression.

Carreno FR, Frazer A. Carreno FR, et al. Among authors: frazer a. Neurotherapeutics. 2017 Jul;14(3):716-727. doi: 10.1007/s13311-017-0537-8. Neurotherapeutics. 2017. PMID: 28585221 Free PMC article. Review.

2

Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain.

Furmaga H, Carreno FR, Frazer A. Furmaga H, et al. Among authors: frazer a. PLoS One. 2012;7(5):e34844. doi: 10.1371/journal.pone.0034844. Epub 2012 May 1. PLoS One. 2012. PMID: 22563458 Free PMC article.

3

Activation of signaling pathways downstream of the brain-derived neurotrophic factor receptor, TrkB, in the rat brain by vagal nerve stimulation and antidepressant drugs.

Carreno FR, Frazer A. Carreno FR, et al. Among authors: frazer a. Int J Neuropsychopharmacol. 2014 Feb;17(2):247-58. doi: 10.1017/S1461145713000977. Epub 2013 Oct 8. Int J Neuropsychopharmacol. 2014. PMID: 24103847 Free article.

4

Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.

Perez SM, Carreno FR, Frazer A, Lodge DJ. Perez SM, et al. Among authors: frazer a. J Neurosci. 2014 Jul 9;34(28):9261-7. doi: 10.1523/JNEUROSCI.0588-14.2014. J Neurosci. 2014. PMID: 25009259 Free PMC article.

5

Therapeutic modalities for treatment resistant depression: focus on vagal nerve stimulation and ketamine.

Shah A, Carreno FR, Frazer A. Shah A, et al. Among authors: frazer a. Clin Psychopharmacol Neurosci. 2014 Aug;12(2):83-93. doi: 10.9758/cpn.2014.12.2.83. Epub 2014 Aug 12. Clin Psychopharmacol Neurosci. 2014. PMID: 25191499 Free PMC article. Review.

6

The Allure of Transcutaneous Vagus Nerve Stimulation as a Novel Therapeutic Modality.

Carreno FR, Frazer A. Carreno FR, et al. Among authors: frazer a. Biol Psychiatry. 2016 Feb 15;79(4):260-1. doi: 10.1016/j.biopsych.2015.11.016. Biol Psychiatry. 2016. PMID: 26796874 No abstract available.

7

Role of TrkB in the anxiolytic-like and antidepressant-like effects of vagal nerve stimulation: Comparison with desipramine.

Shah AP, Carreno FR, Wu H, Chung YA, Frazer A. Shah AP, et al. Among authors: frazer a. Neuroscience. 2016 May 13;322:273-86. doi: 10.1016/j.neuroscience.2016.02.024. Epub 2016 Feb 16. Neuroscience. 2016. PMID: 26899129 Free PMC article.

8

Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.

Carreno FR, Donegan JJ, Boley AM, Shah A, DeGuzman M, Frazer A, Lodge DJ. Carreno FR, et al. Among authors: frazer a. Mol Psychiatry. 2016 Sep;21(9):1298-308. doi: 10.1038/mp.2015.176. Epub 2015 Dec 1. Mol Psychiatry. 2016. PMID: 26619811

9

Selective Pharmacological Augmentation of Hippocampal Activity Produces a Sustained Antidepressant-Like Response without Abuse-Related or Psychotomimetic Effects.

Carreno FR, Collins GT, Frazer A, Lodge DJ. Carreno FR, et al. Among authors: frazer a. Int J Neuropsychopharmacol. 2017 Jun 1;20(6):504-509. doi: 10.1093/ijnp/pyx003. Int J Neuropsychopharmacol. 2017. PMID: 28339593 Free PMC article.

10

Ketamine: Leading us into the future for development of antidepressants.

Carreno FR, Lodge DJ, Frazer A. Carreno FR, et al. Among authors: frazer a. Behav Brain Res. 2020 Apr 6;383:112532. doi: 10.1016/j.bbr.2020.112532. Epub 2020 Feb 2. Behav Brain Res. 2020. PMID: 32023492 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters